Showing results (331-340 of 579) with videos related to

Sort By:
Pageof 58
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[A phase II multicenter study to investigate R-ICE as a salvage therapy for relapsed diffuse large B-cell lymphoma]Ye Guo, Yu Chen, Xiaonan Hong, et al.
Gut Microbes|April 7, 2025
Raffinose-metabolizing bacteria impair radiation-associated hematopoietic recovery <i>via</i> the bile acid/FXR/NF-κB signaling pathwayYang Jiao, Jiawei Ren, Shichang Xie, et al.
Frontiers in Oncology|June 23, 2022
The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in ChinaJinyan Xiao, Zihong Cai, Hao Wang, et al.
Experimental Hematology & Oncology|April 10, 2023
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patientsYunju Ma, Haiping Dai, Qingya Cui, et al.
Frontiers in Immunology|September 19, 2022
The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world studyXiya Wei, Yiyu Xie, Ruoyu Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2026
Targeting PRKCN, an Essential Driver Orchestrating mTOR-IRF4 Axis Independently of Kinase Activity, in Multiple MyelomaKoukou Tang, Dongpeng Jiang, Peng Ke, et al.
European Journal of Immunology|July 17, 2020
BRCC36 functions noncatalytically to promote antiviral response by maintaining STAT1 protein stabilityQiao Cheng, Qian Feng, Yang Xu, et al.
Nature Communications|June 24, 2026
Neutrophil-derived S100A8/A9 impairs megakaryocyte maturation in immune thrombocytopeniaJiaqian Qi, Meng Zhou, Jie Yin, et al.
Plos One|October 14, 2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantationXiaoyu Xu, Xinxin Ge, Airui Jiang, et al.
Annals of Internal Medicine|March 24, 2020
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized TrialEmanuele Angelucci, Junmin Li, Peter Greenberg, et al.
Pageof 58